The SERD (Selective Estrogen Receptor Degrader) therapeutics market is witnessing substantial growth due to the rising prevalence of estrogen receptor-positive (ER+) breast cancer and advancements in targeted therapies. From innovative treatments to market dynamics, this analysis equips stakeholders with essential knowledge for strategic decision-making @ SERD Therapeutics Market Share This...